Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 39,453 GPCR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Structure Therapeutics Inc. (GPCR) | Grant/Award | 39,453 | n/a |
| Jun 13, 2026 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 5,500 | n/a |
| Jun 11, 2026 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 34,843 | n/a |
| Jun 25, 2025 | Structure Therapeutics Inc. (GPCR) | Grant/Award | 51,804 | n/a |
| Jun 13, 2025 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 3,750 | n/a |
| May 1, 2025 | Jade Biosciences, Inc. (JBIO) | Grant/Award | 23,017 | n/a |
| Jul 22, 2024 | Janux Therapeutics, Inc. (JANX) | Grant/Award | 5,000 | n/a |
| Jun 27, 2024 | Structure Therapeutics Inc. (GPCR) | Grant/Award | 37,500 | n/a |
| Nov 14, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Purchase | 446,825 | $101.3K |
| Jun 2, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 57,000 | n/a |